Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥3,340 JPY
Change Today +85.00 / 2.61%
Volume 1.7M
4543 On Other Exchanges
Symbol
Exchange
Munich
Tokyo
OTC US
OTC US
As of 2:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for terumo corp (4543)

Year over year, Terumo Corporation has been able to grow revenues from ¥467.4B JPY to ¥489.5B JPY. Most impressively, the company has been able to reduce the percentage of sales devoted to cost of goods sold from 48.22% to 47.70%. This was a driver that led to a bottom line growth from ¥34.1B JPY to ¥38.5B JPY.
View Income Statement In U.S. Dollar
Currency in
Millions of Japanese Yens
As of:Mar 31
2012
JPY
Mar 31
2013
JPY
Mar 31
2014
JPY
Mar 31
2015
JPY
4 Year
Trend
Revenues386,686.0402,294.0467,359.0489,506.0
TOTAL REVENUES386,686.0402,294.0467,359.0489,506.0
Cost of Goods Sold182,046.0196,605.0225,348.0233,480.0
GROSS PROFIT204,640.0205,689.0242,011.0256,026.0
Selling General & Admin Expenses, Total107,401.0115,039.0146,592.0159,209.0
R&D Expenses24,322.027,128.030,130.029,360.0
Depreciation & Amortization, Total9,867.010,305.0----
OTHER OPERATING EXPENSES, TOTAL141,590.0152,472.0176,722.0188,569.0
OPERATING INCOME63,050.053,217.065,289.067,457.0
Interest Expense-738.0-1,303.0-1,542.0-1,254.0
Interest and Investment Income682.0591.0797.0931.0
NET INTEREST EXPENSE-56.0-712.0-745.0-323.0
Income (Loss) on Equity Investments57.0176.0132.0-65.0
Currency Exchange Gains (Loss)-990.01,257.03,250.06,598.0
Other Non-Operating Income (Expenses)-1,170.0-1,885.0-3,289.0-2,672.0
EBT, EXCLUDING UNUSUAL ITEMS60,891.052,053.064,637.070,995.0
Gain (Loss) on Sale of Investments-9,316.0-----38.0
Gain (Loss) on Sale of Assets-1,748.0-1,143.0-1,088.0-735.0
Other Unusual Items, Total-178.01,375.0-10,643.0-6,177.0
Other Unusual Items43.01,378.04,708.0-4,552.0
EBT, INCLUDING UNUSUAL ITEMS49,649.052,285.052,906.064,045.0
Income Tax Expense25,425.05,218.018,780.025,575.0
Minority Interest in Earnings-57.0-53.0-30.0--
Earnings from Continuing Operations24,224.047,067.034,126.038,470.0
NET INCOME24,167.047,014.034,096.038,470.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS24,167.047,014.034,096.038,470.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS24,167.047,014.034,096.038,470.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4543:JP ¥3,340.00 JPY +85.00

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $197.47 USD +0.98
Edwards Lifesciences Corp $144.70 USD -0.89
Hospira Inc $89.93 USD +0.01
Olympus Corp ¥4,440 JPY +140.00
Teleflex Inc $132.49 USD -0.61
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 29.7x
Price/Sales 2.5x
Price/Book 2.2x
Price/Cash Flow 28.6x
TEV/Sales 1.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TERUMO CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.